Heterologous expression and characterization of the bifunctional dihydrofolate reductase-thymidylate synthase enzyme of Toxoplasma gondii

被引:59
作者
Trujillo, M
Donald, RGK
Roos, DS
Greene, PJ
Santi, DV
机构
[1] UNIV CALIF SAN FRANCISCO, DEPT BIOCHEM & BIOPHYS, SAN FRANCISCO, CA 94143 USA
[2] UNIV CALIF SAN FRANCISCO, DEPT PHARMACEUT CHEM, SAN FRANCISCO, CA 94143 USA
[3] UNIV PENN, DEPT BIOL, PHILADELPHIA, PA 19104 USA
关键词
D O I
10.1021/bi952923q
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
We have expressed catalytically active Toxoplasma gondii dihydrofolate-thymidylate synthase (DHFR-TS) and the individual TS and DHFR domains in Escherichia coli using the T7 promoter of pET-15b. DHFR-TS constituted approximately 10% of the total soluble cell protein and was purified using methotrexate-Sepharose chromatography to yield 10 mg of homogeneous DHFR-TS per liter of culture. The DHFR domain was recovered as insoluble inclusion bodies which could be unfolded and refolded to recover soluble, active enzyme, The TS domain was overexpressed as a soluble protein by growing the cells at 24 degrees C; this is the first report of the expression of an active TS domain from a bifunctional enzyme. The k(cat) and K-m values for DHFR-TS are similar to those of other previously characterized protozoan DHFRs and TSs, The antimicrobial antifolates, TMP and Pyr, inhibit DHFR activity of the bifunctional protein in accord with their effects in crude enzyme preparations and in vivo systems, Kinetic parameters and Ki values for TMP and Pyr with the isolated DHFR domain were identical to the values for DHFR in the bifunctional enzyme. Evidence of kinetic channeling of the dihydrofolate product of TS to the DHFR domain in the bifunctional enzyme was obtained by kinetic and inhibition studies, Properties such as yield, stability, and activities of the recombinant T. gondii DHFR-TS provide clear advantages over other bifunctional DHFR-TSs as a model for future studies.
引用
收藏
页码:6366 / 6374
页数:9
相关论文
共 42 条
[1]  
ACKERMANN WW, 1949, P SOC EXP BIOL MED, V72, P1
[2]   CONSTRUCTION OF A FOL MUTANT STRAIN OF ESCHERICHIA-COLI FOR USE IN DIHYDROFOLATE-REDUCTASE MUTAGENESIS EXPERIMENTS [J].
AHRWEILER, PM ;
FRIEDEN, C .
JOURNAL OF BACTERIOLOGY, 1988, 170 (07) :3301-3304
[3]   PROPHYLAXIS FOR TOXOPLASMOSIS IN AIDS [J].
BEAMAN, MH ;
LUFT, BJ ;
REMINGTON, JS .
ANNALS OF INTERNAL MEDICINE, 1992, 117 (02) :163-164
[4]  
Blakley R. L., 1984, FOLATES PTERINS, P191
[5]  
BOLIN JT, 1982, J BIOL CHEM, V257, P13650
[6]  
BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3
[7]   THE CATALYTIC MECHANISM AND STRUCTURE OF THYMIDYLATE SYNTHASE [J].
CARRERAS, CW ;
SANTI, DV .
ANNUAL REVIEW OF BIOCHEMISTRY, 1995, 64 :721-762
[8]   IDENTIFICATION OF HIGHLY POTENT AND SELECTIVE INHIBITORS OF TOXOPLASMA-GONDII DIHYDROFOLATE-REDUCTASE [J].
CHIO, LC ;
QUEENER, SF .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1993, 37 (09) :1914-1923
[9]   CRYSTAL-STRUCTURES OF RECOMBINANT HUMAN DIHYDROFOLATE-REDUCTASE COMPLEXED WITH FOLATE AND 5-DEAZAFOLATE [J].
DAVIES, JF ;
DELCAMP, TJ ;
PRENDERGAST, NJ ;
ASHFORD, VA ;
FREISHEIM, JH ;
KRAUT, J .
BIOCHEMISTRY, 1990, 29 (40) :9467-9479
[10]   HOMOLOGOUS RECOMBINATION AND GENE REPLACEMENT AT THE DIHYDROFOLATE REDUCTASE-THYMIDYLATE SYNTHASE LOCUS IN TOXOPLASMA-GONDII [J].
DONALD, RGK ;
ROOS, DS .
MOLECULAR AND BIOCHEMICAL PARASITOLOGY, 1994, 63 (02) :243-253